The program now serves 6 million patients, and Elevance sees it as something that sets it apart from the competition.

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Elevance Health (ELV – Research Report) yesterday and set a price target of ...

Elevance Health posted first quarter results Tuesday that beat analyst expectations, with the Indianapolis-based health insurance giant also reaffirming its earnings forecast for the year amid ...

$2,520,000 of ELEVANCE HEALTH INC. lobbying was just disclosed ... Contracting Clauses Act No Suprises Act Implementation Physician Led and Rural Access to Quality Care Act (H.R. 2191) Full ...

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

Elevance Health lowered its profit guidance but held tight on its adjusted earnings target for the year after higher yields and more members boosted first-quarter revenue.

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs. its $11.63. The company cites medical costs ...

(Reuters) - U.S. health insurer Elevance Health spent less than expected on medical care in the first quarter and said on Tuesday that demand for healthcare services among older adults was ...

Elevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street estimates.